|
Role of SLC13A3 in Renal Cell Carcinoma
|
5F31CA210612-02
|
$33,744
|
$33,744
|
JORDAN, ANDRE
|
AUGUSTA UNIVERSITY
|
|
Dietary Combination For Prevention of Metastatic Renal Cell Carcinoma
|
5R01CA176691-04
|
|
$0
|
LOKESHWAR, VINATA
|
AUGUSTA UNIVERSITY
|
|
Combating Resistance to Antiangiogenic Therapy in Renal Cell Carcinoma
|
5R01CA196996-03
|
$398,025
|
$398,025
|
BHATT, RUPAL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
DF/HCC Kidney Cancer SPORE
|
5P50CA101942-13
|
$2,300,000
|
$2,300,000
|
MCDERMOTT, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Regulation of the LIN28/let-7 pathway in cancer
|
1R01CA211328-01
|
$404,888
|
$404,888
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Novel Role(s) of Nrf2 in the Growth of Post-Transplantation Cancer
|
5R01CA193675-02
|
$411,185
|
$411,185
|
PAL, SOUMITRO
|
BOSTON CHILDREN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
$41,770
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
$222,902
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S1
|
$118,875
|
$1,189
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S2
|
$60,000
|
$600
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S3
|
$200,000
|
$2,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-27S4
|
$145,821
|
$1,458
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-27
|
$4,895,515
|
$48,955
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
3U10CA180853-04S1
|
$76,498
|
$1,912
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-04
|
$1,188,450
|
$29,711
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
COG NCTN Network Group Operations Center
|
3U10CA180886-04S1
|
$1,393,520
|
$83,611
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-04
|
$400,000
|
$80,000
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-04
|
$22,547,116
|
$1,352,827
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Bench to bedside: non-invasive treatment of tumors in children
|
1U01CA202947-01A1
|
$350,585
|
$87,646
|
KIM, PETER
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Regulation of MDSC function and trafficking
|
5R01CA168488-05
|
$376,829
|
$376,829
|
FINKE, JAMES
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Defining the functions and translational potential of ferroptosis
|
5R35CA209896-02
|
$955,184
|
$315,211
|
STOCKWELL, BRENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$1,200
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$600
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$1,187
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$1,995
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$37,927
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S2
|
$60,000
|
$1,200
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S3
|
$100,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
|
5U10CA180867-04
|
$1,302,199
|
$48,832
|
BURSTEIN, HAROLD
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
2P30CA006516-52
|
$11,592,798
|
$231,856
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
Dana-Farber/Harvard Cancer Center
|
3P30CA006516-52S1
|
$112,500
|
$2,250
|
GLIMCHER, LAURIE
|
DANA-FARBER CANCER INST
|
|
New Paradigms for Targeting Truncal Driver Mutations
|
5R35CA210068-02
|
$982,500
|
$491,250
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INST
|
|
Cross-species identification and validation of synthetic lethal relationships with VHL inactivation
|
1F32CA220849-01
|
$56,694
|
$56,694
|
NICHOLSON, HILARY
|
DANA-FARBER CANCER INST
|
|
Misassembled BAF complexes in human cancer: structural and functional consequences
|
5F31CA196218-03
|
$29,705
|
$14,853
|
POYNTER, STEVEN
|
DANA-FARBER CANCER INST
|
|
Role of SNF5 in regulating SWI/SNF complex assembly & targeting in rhabdoid tumor
|
5K99CA197640-02
|
$151,649
|
$151,649
|
WANG, XIAOFENG
|
DANA-FARBER CANCER INST
|
|
Dartmouth Lead Participation in NCI National Clinical Trials Network
|
5U10CA180854-04
|
$357,058
|
$17,853
|
DRAGNEV, KONSTANTIN
|
DARTMOUTH COLLEGE
|
|
NCI National Clinical Trials Network U10
|
5U10CA180857-04
|
$392,946
|
$9,824
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$20,355
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
5U10CA180828-04
|
$637,150
|
$31,858
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
3R01CA054498-25S1
|
$44,259
|
$44,259
|
LEISENRING, WENDY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Obesity Paradox in Renal Cell Carcinoma
|
5R03CA195098-02
|
$84,825
|
$84,825
|
WILSON, KATHRYN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
The role of Lin28/let 7 pathway in Wilms' tumor
|
5F99CA212487-02
|
$31,994
|
$31,994
|
YERMALOVICH, ALENA
|
HARVARD UNIVERSITY
|
|
Integrated Tools for Quantitative Whole-Body Tumor Perfusion Imaging
|
5R01CA202695-02
|
$566,413
|
$192,580
|
HUTCHINS, GARY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-18S1
|
$106,993
|
$7,490
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-18S2
|
$129,129
|
$9,039
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-18S3
|
$111,340
|
$7,794
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-18S4
|
$174,294
|
$12,201
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
3P30CA082709-18S5
|
$250,000
|
$17,500
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Indiana University Melvin and Bren Simon Cancer Center Support Grant
|
5P30CA082709-18
|
$2,184,000
|
$152,880
|
LOEHRER, PATRICK
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Regulation of Mdm2 activity by kinase signaling pathways
|
3R01CA172256-05S1
|
$88,200
|
$88,200
|
MAYO, LINDSEY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
Total relevant funding to Kidney Disease for this search: $47,723,327
|